Peike Peng

1.2k total citations
25 papers, 852 citations indexed

About

Peike Peng is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Peike Peng has authored 25 papers receiving a total of 852 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 9 papers in Oncology and 9 papers in Immunology. Recurrent topics in Peike Peng's work include Glycosylation and Glycoproteins Research (4 papers), Liver Disease Diagnosis and Treatment (4 papers) and Galectins and Cancer Biology (4 papers). Peike Peng is often cited by papers focused on Glycosylation and Glycoproteins Research (4 papers), Liver Disease Diagnosis and Treatment (4 papers) and Galectins and Cancer Biology (4 papers). Peike Peng collaborates with scholars based in China, Australia and United States. Peike Peng's co-authors include Yuanyuan Ruan, Jianxin Gu, Weicheng Wu, Dongwei Jia, Miaomiao Shao, Shushu Song, Hao Wu, Mingming Zhang, Junjie Zhao and Caiting Yang and has published in prestigious journals such as Nature Communications, Gastroenterology and PLoS ONE.

In The Last Decade

Peike Peng

25 papers receiving 847 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Peike Peng China 16 453 272 179 148 83 25 852
Yuanyuan Ruan China 17 581 1.3× 350 1.3× 223 1.2× 174 1.2× 81 1.0× 34 998
Miaomiao Shao China 15 458 1.0× 245 0.9× 233 1.3× 151 1.0× 53 0.6× 33 742
Yeong Seok Kim South Korea 20 408 0.9× 236 0.9× 116 0.6× 202 1.4× 66 0.8× 51 907
Xianxi Wang United States 15 728 1.6× 339 1.2× 231 1.3× 248 1.7× 56 0.7× 28 1.2k
Zhenyu Cai China 16 927 2.0× 396 1.5× 169 0.9× 154 1.0× 59 0.7× 28 1.2k
Ga Bin Park South Korea 20 475 1.0× 246 0.9× 169 0.9× 210 1.4× 77 0.9× 49 925
Thangirala Sudha United States 23 655 1.4× 149 0.5× 177 1.0× 214 1.4× 87 1.0× 46 1.2k
Manhua Cui China 18 591 1.3× 194 0.7× 212 1.2× 214 1.4× 39 0.5× 55 984

Countries citing papers authored by Peike Peng

Since Specialization
Citations

This map shows the geographic impact of Peike Peng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peike Peng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peike Peng more than expected).

Fields of papers citing papers by Peike Peng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peike Peng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peike Peng. The network helps show where Peike Peng may publish in the future.

Co-authorship network of co-authors of Peike Peng

This figure shows the co-authorship network connecting the top 25 collaborators of Peike Peng. A scholar is included among the top collaborators of Peike Peng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peike Peng. Peike Peng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Shao, Miaomiao, Dongwei Jia, Wenli Lü, et al.. (2025). Calceolarioside B targets MMP12 in the tumor microenvironment to inhibit M2 macrophage polarization and suppress hepatocellular carcinoma progression. Phytomedicine. 142. 156805–156805. 2 indexed citations
2.
Li, Mingzhe, Fangfang Duan, Zhiqiang Pan, et al.. (2023). Astragalus Polysaccharide Promotes Doxorubicin-Induced Apoptosis by Reducing O-GlcNAcylation in Hepatocellular Carcinoma. Cells. 12(6). 866–866. 24 indexed citations
3.
Xu, Shihao, Xi Qiao, Peike Peng, et al.. (2022). Da-Chai-Hu-Tang Protects From Acute Intrahepatic Cholestasis by Inhibiting Hepatic Inflammation and Bile Accumulation via Activation of PPARα. Frontiers in Pharmacology. 13. 847483–847483. 7 indexed citations
4.
Jia, Dongwei, et al.. (2022). α-Hederin inhibits the platelet activating factor-induced metastasis of HCC cells through disruption of PAF/PTAFR axis cascaded STAT3/MMP-2 expression. Pharmacological Research. 178. 106180–106180. 21 indexed citations
5.
Sun, Haitao, Tianzhu Yu, Xin Li, et al.. (2021). Second near-infrared photothermal-amplified immunotherapy using photoactivatable composite nanostimulators. Journal of Nanobiotechnology. 19(1). 433–433. 41 indexed citations
6.
Song, Shushu, Yongyong Shi, Weicheng Wu, et al.. (2020). Reticulon 3-mediated Chk2/p53 activation suppresses hepatocellular carcinogenesis and is blocked by hepatitis B virus. Gut. 70(11). 2159–2171. 41 indexed citations
7.
8.
Yang, Tao, et al.. (2018). Akebia trifoliata (Thunb.) Koidz Seed Extract inhibits human hepatocellular carcinoma cell migration and invasion in vitro. Journal of Ethnopharmacology. 234. 204–215. 17 indexed citations
10.
Song, Shushu, Peike Peng, Zhaoqing Tang, et al.. (2017). Decreased expression of STING predicts poor prognosis in patients with gastric cancer. Scientific Reports. 7(1). 39858–39858. 170 indexed citations
11.
Li, Lili, Miaomiao Shao, Peike Peng, et al.. (2017). High expression of GFAT1 predicts unfavorable prognosis in patients with hepatocellular carcinoma. Oncotarget. 8(12). 19205–19217. 38 indexed citations
12.
Wang, Lan, Jie Yin, Xuefei Wang, et al.. (2016). C-Type Lectin-Like Receptor 2 Suppresses AKT Signaling and Invasive Activities of Gastric Cancer Cells by Blocking Expression of Phosphoinositide 3-Kinase Subunits. Gastroenterology. 150(5). 1183–1195.e16. 49 indexed citations
13.
Zhao, Ran, Xiaoxia Liu, Yisheng Wang, et al.. (2016). Integrated glycomic analysis of ovarian cancer side population cells. Clinical Proteomics. 13(1). 32–32. 13 indexed citations
14.
Peng, Peike, Weicheng Wu, Junjie Zhao, et al.. (2016). Decreased expression of Calpain-9 predicts unfavorable prognosis in patients with gastric cancer. Scientific Reports. 6(1). 29604–29604. 23 indexed citations
15.
Yang, Caiting, Peike Peng, Lili Li, et al.. (2016). High expression of GFAT1 predicts poor prognosis in patients with pancreatic cancer. Scientific Reports. 6(1). 39044–39044. 53 indexed citations
16.
Shao, Miaomiao, Lili Li, Shushu Song, et al.. (2016). E3 ubiquitin ligase CHIP interacts with C-type lectin-like receptor CLEC-2 and promotes its ubiquitin-proteasome degradation. Cellular Signalling. 28(10). 1530–1536. 9 indexed citations
17.
Wang, Jiajun, Miaomiao Shao, Min Liu, et al.. (2015). PKCα promotes generation of reactive oxygen species via DUOX2 in hepatocellular carcinoma. Biochemical and Biophysical Research Communications. 463(4). 839–845. 14 indexed citations
18.
Liu, Min, Peike Peng, Jiajun Wang, et al.. (2015). RACK1-mediated translation control promotes liver fibrogenesis. Biochemical and Biophysical Research Communications. 463(3). 255–261. 12 indexed citations
19.
Jia, Dongwei, Fangfang Duan, Peike Peng, et al.. (2015). Pyrroloquinoline-Quinone Suppresses Liver Fibrogenesis in Mice. PLoS ONE. 10(3). e0121939–e0121939. 27 indexed citations
20.
Jia, Dongwei, Peike Peng, Linlin Sun, et al.. (2013). Up-Regulation of RACK1 by TGF-β1 Promotes Hepatic Fibrosis in Mice. PLoS ONE. 8(3). e60115–e60115. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026